Clinical and pharmacological aspects of (-)-deprenyl treatment in Parkinson's disease.
D000661:Amphetamine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
D010627:Phenethylamines; D012642:Selegiline; D000661:Amphetamine